The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19
NCT ID: NCT04505761
Last Updated: 2021-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2020-08-01
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Yet, the resources needed to provide rehabilitation treatment to COVID-19 patients are inadequate because healthcare systems faced a shortage of high-quality treatment for these impairments already before the COVID-19 crisis emerged. Virtual Reality (VR) provides potential to healthcare practitioners to administer fast, temporary, and tailor-made rehabilitation services at a distance, and offers a solution to address the impending surge of demand for rehabilitation after COVID-19 infection. VR consists of a head mounted display (HMD) that can bring the user by computer-generated visuals into an immersive, realistic multi-sensory environment. Current VR technology is accessible, easy in use for a large audience, and safe in use. There already exist multiple VR applications for providing physical, psychological, and cognitive rehabilitation. These applications have been brought together in a VR suite for rehabilitation after COVID-19. Patients visiting a physiotherapist for rehabilitation from COVID-19 will be asked to participate in this study. They receive a VR HMD for training purposes. This study aims to understand the usability, feasibility, and tolerability of VR for rehabilitation after COVID-19, and to pilot the effectiveness of VR improving the physical ability, mental and cognitive status of patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality Study - COVID-19 Protocol
NCT04678778
Virtual Reality Stimulation to Enhance Cognitive Function of Intensive Care Unit Patients
NCT03025373
Enhancing Brain Training With Virtual Reality
NCT03582579
Neurocognitive Rehabilitation Using Virtual Reality
NCT04017091
Digital Multimodal Rehabilitation for People With Post-acute COVID-19 Syndrome.
NCT05846126
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Participants will receive Virtual Reality as an add-on to standard physiotherapy after COVID-19.
Virtual Reality
Participants will use a Virtual Reality headset with a range of applications applicable for rehabilitation after COVID-19. Applications target physical, psychological, and cognitive rehabilitation. VR headset will be used for six weeks first at the physiotherapist's practice, and when possible, at home.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual Reality
Participants will use a Virtual Reality headset with a range of applications applicable for rehabilitation after COVID-19. Applications target physical, psychological, and cognitive rehabilitation. VR headset will be used for six weeks first at the physiotherapist's practice, and when possible, at home.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient has an indication for physical therapy in the context of rehabilitation after COVID-19.
3. At the day of recruitment, the estimated length of the physical therapy is at least 3 weeks after inclusion.
4. Patient is willing and able to comply with the study protocol.
5. Patient is at least 16 years old on the day the informed consent form will be signed.
6. Patient can read and understand the Dutch language.
Exclusion Criteria
2. Patient has difficulties to handle virtual reality:
1. Patient suffers from delirium or acute confusional state.
2. Patient has (a history of) dementia, seizure, or epilepsy.
3. Patient has severe hearing/visual impairment not corrected.
4. The skin of the patient's head or face is not intact (for example head wounds, psoriasis, eczema).
3. Patient has a high risk of contamination with a therapy resistant micro-organism e.g. MRSA.
4. Patients suffers from severe anxiety or depression (HADSā„16).
5. Red flags (see Appendix 1).
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Radboud University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Harry van Goor, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Radboud University Medical Center
Bart Staal, PT, PhD
Role: PRINCIPAL_INVESTIGATOR
Radboud University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Radboud university medical center
Nijmegen, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Groenveld T, Achttien R, Smits M, de Vries M, van Heerde R, Staal B, van Goor H; COVID Rehab Group. Feasibility of Virtual Reality Exercises at Home for Post-COVID-19 Condition: Cohort Study. JMIR Rehabil Assist Technol. 2022 Aug 15;9(3):e36836. doi: 10.2196/36836.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVRehab
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.